AAAAAA
Results:
1-21
|
Results: 21
Authors:
HONG WW
RAK IW
CIURYLA VT
WILSON AM
KYLSTRA JW
MELTZER HY
CARPENTER WT
LEHMAN A
ARVANITIS LA
Citation: Ww. Hong et al., MEDICAL-CLAIMS DATABASES IN THE DESIGN OF A HEALTH-OUTCOMES COMPARISON OF QUETIAPINE (SEROQUEL) AND USUAL-CARE ANTIPSYCHOTIC MEDICATION, Schizophrenia research, 32(1), 1998, pp. 51-58
Authors:
ARVANITIS LA
RAK IW
Citation: La. Arvanitis et Iw. Rak, EFFICACY, SAFETY AND TOLERABILITY OF SEROQUEL (QUETIAPINE) IN ELDERLYSUBJECTS WITH PSYCHOTIC DISORDERS, Schizophrenia research, 24(1-2), 1997, pp. 196-196
Authors:
ARVANITIS LA
RAK IW
Citation: La. Arvanitis et Iw. Rak, THE LONG-TERM EFFICACY AND SAFETY OF SEROQUEL (QUETIAPINE), Schizophrenia research, 24(1-2), 1997, pp. 196-197
Authors:
GOLDSTEIN JM
ARVANITIS LA
Citation: Jm. Goldstein et La. Arvanitis, SEROQUEL (QUETIAPINE), A PROMISING NEW ANTIPSYCHOTIC AGENT - OVERVIEWOF SAFETY AND TOLERABILITY, Schizophrenia research, 24(1-2), 1997, pp. 197-197
Authors:
GOLDSTEIN JM
ARVANITIS LA
Citation: Jm. Goldstein et La. Arvanitis, SEROQUEL (QUETIAPINE) IS NOT ASSOCIATED WITH DOSE-RELATED EXTRAPYRAMIDAL SYMPTOMS - OVERVIEW OF CLINICAL-RESULTS, Schizophrenia research, 24(1-2), 1997, pp. 198-198
Authors:
RAK IW
ARVANITIS LA
Citation: Iw. Rak et La. Arvanitis, OVERVIEW OF THE EFFICACY OF SEROQUEL (QUETIAPINE), Schizophrenia research, 24(1-2), 1997, pp. 199-199
Authors:
CANTILLON M
ARVANITIS LA
Citation: M. Cantillon et La. Arvanitis, CLINICAL-EXPERIENCE WITH QUETIAPINE, AN ATYPICAL ANTIPSYCHOTIC AGENT, Psychopharmacology bulletin, 33(3), 1997, pp. 502-502
Authors:
TARGUM SD
ARVANITIS LA
Citation: Sd. Targum et La. Arvanitis, QUETIAPINE - EFFICACY, SAFETY, AND TOLERABILITY IN ELDERLY SUBJECTS WITH PSYCHOTIC DISORDERS, Psychopharmacology bulletin, 33(3), 1997, pp. 595-595
Authors:
MCMANUS DQ
RAK IW
ARVANITIS LA
Citation: Dq. Mcmanus et al., SAFETY AND TOLERABILITY OF SEROQUEL(R)(QUETIAPINE) IN ELDERLY SUBJECTS WITH PSYCHOSIS, Neurology, 48(3), 1997, pp. 2027-2027
Authors:
ARVANITIS LA
MILLER BG
BORISON RL
PITTS WM
SHARIF ZA
HAMNER MB
HERZ MI
TRUE JE
VELLIGAN D
KNESEVICH MA
SMALL J
STEINBOOK R
HERTZMAN M
KECK PE
NEWCOMER JW
GRACE J
ROTROSEN J
TANDON R
DOTT SG
FERGUSON JM
ADDINGTON DEN
MACEWAN GW
NAIR VNP
SHRIQUI CL
WILLIAMS R
DANIEL DG
SHEHI GM
PATTERSON WM
MERIDETH CH
Citation: La. Arvanitis et al., MULTIPLE FIXED DOSES OF SEROQUEL (QUETIAPINE) IN PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA - A COMPARISON WITH HALOPERIDOL AND PLACEBO, Biological psychiatry, 42(4), 1997, pp. 233-246
Authors:
SMALL JG
HIRSCH SR
ARVANITIS LA
MILLER BG
LINK CGG
MURPHY AL
BOWDEN CL
OBRIEN CP
STEINBOOK RM
WAGNER RL
PITTS WM
CRABTREE B
CORRIGAN MHN
LOHR JB
MILLER AL
ERESHEFSKY L
ANDERSON CB
KNESEVICH MA
ROTROSEN J
OWEN RR
KARSON CN
LINDENMAYER JP
PFEFFERBAUM A
FAUSTMAN WO
KECK PE
PATTERSON WM
RIESENBERG RA
GLADSON MB
KOLIN IS
BARNES TRE
SENSKY T
RICCIO M
FRANKS S
JOLLEY A
HALLSTROM C
BENNIE E
DARCOURT G
PATRIS M
DESILVA M
PATEL AG
FLEISCHHACKER WW
DIETZEL M
SEIFERTOVA D
VINAR O
FALTUS F
BITTER I
OZSVATH K
SHAW SH
MAHAPATRA SN
SZULECKA TK
SUNDARARAJAN K
CREAVEN F
LYNCH J
KLIESER E
COOPER SJ
ASCHAUER H
Citation: Jg. Small et al., QUETIAPINE IN PATIENTS WITH SCHIZOPHRENIA - A HIGH-DOSE AND LOW-DOSE DOUBLE-BLIND COMPARISON WITH PLACEBO, Archives of general psychiatry, 54(6), 1997, pp. 549-557
Authors:
BORISON RL
ARVANITIS LA
MILLER BG
Citation: Rl. Borison et al., A COMPARISON OF 5 FIXED DOSES OF SEROQUEL (ICI-204,636) WITH HALOPERIDOL AND PLACEBO IN PATIENTS WITH SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, pp. 1-1
Authors:
BORISON RL
ARVANITIS LA
MILLER BG
ALPHS LD
CARMAN JS
DIAMOND B
GEWIRTZ G
HAMNER MB
HIRSHFIELD R
MCEVOY JP
MUKHERJEE S
NASRALLAH HA
OXENKRUG G
RYAN W
SMITH N
TAMMINGA C
Citation: Rl. Borison et al., ICI-204,636, AN ATYPICAL ANTIPSYCHOTIC - EFFICACY AND SAFETY IN A MULTICENTER, PLACEBO-CONTROLLED TRIAL IN PATIENTS WITH SCHIZOPHRENIA, Journal of clinical psychopharmacology, 16(2), 1996, pp. 158-169
Authors:
ARVANITIS LA
MILLER BG
Citation: La. Arvanitis et Bg. Miller, ICI-204,636, AN ATYPICAL ANTIPSYCHOTIC RESULTS FROM A MULTIPLE FIXED-DOSE, PLACEBO-CONTROLLED TRIAL, Psychopharmacology bulletin, 32(3), 1996, pp. 391-391
THE ATYPICAL PROFILE OF ICI-204,636 IS SUPPORTED BY ITS LACK OF INDUCTION OF EXTRAPYRAMIDAL SYMPTOMS
Authors:
HONG WW
ARVANITIS LA
MILLER BG
LINK CGG
Citation: Ww. Hong et al., THE ATYPICAL PROFILE OF ICI-204,636 IS SUPPORTED BY ITS LACK OF INDUCTION OF EXTRAPYRAMIDAL SYMPTOMS, Psychopharmacology bulletin, 32(3), 1996, pp. 458-458
Authors:
HAMNER MB
ARVANITIS LA
MILLER BG
LINK CGG
HONG WW
Citation: Mb. Hamner et al., PLASMA PROLACTIN IN SCHIZOPHRENIA SUBJECTS TREATED WITH SEROQUEL(TM) (ICI-204,636), Psychopharmacology bulletin, 32(1), 1996, pp. 107-110
Authors:
HIRSCH SR
LINK CGG
GOLDSTEIN JM
ARVANITIS LA
Citation: Sr. Hirsch et al., ICI-204,636 - A NEW ATYPICAL ANTIPSYCHOTIC DRUG, British Journal of Psychiatry, 168, 1996, pp. 45-56
Authors:
BORISON RL
ARVANITIS LA
MILLER BG
Citation: Rl. Borison et al., A MULTIPLE FIXED-DOSE, PLACEBO-CONTROLLED TRIAL WITH SEROQUEL - AN ATYPICAL ANTIPSYCHOTIC, Biological psychiatry, 39(7), 1996, pp. 333-333
Authors:
HONG WW
ARVANITIS LA
MILLER BG
Citation: Ww. Hong et al., SEROQUEL (ICI-204,636) - NOT DIFFERENT FROM PLACEBO FOR EPS OF PROLACTIN, Biological psychiatry, 39(7), 1996, pp. 334-334
Authors:
BORISON RL
ARVANITIS LA
MILLER BG
LINK CGG
HONG WW
Citation: Rl. Borison et al., SEROQUEL (ICI-204,636) - A NOVEL, ATYPICAL ANTIPSYCHOTIC, Biological psychiatry, 37(9), 1995, pp. 661-661
Authors:
HAMNER MB
ARVANITIS LA
MILLER BG
LINK C
HONG WW
Citation: Mb. Hamner et al., THE EFFECTS OF SEROQUEL (ICI-204.636) ON PLASMA PROLACTIN IN PATIENTSWITH SCHIZOPHRENIA, Biological psychiatry, 37(9), 1995, pp. 683-683
Risultati:
1-21
|